NYSE:NVS
Novartis AG
(NYSE:NVS)
87.03
-1.16
(-1.32%)
As of 2022-01-21 Close (EST)
| 52 Week Rng | - |
| Market Cap | - |
| Avg Volume | - |
| 1M Volatility | - |
| Short Ratio | - |
| P/E Ratio (TTM) | - |
| P/E Ratio (Fwd) | - |
| P/B Ratio | - |
| Div & Yield | - |
ACTION
TICKER
SHARES
STATUS
caitlinsheng • Abington 2021 • Jan 2021
industry leader in pharmaceuticals
ACTION
TICKER
SHARES
STATUS
ACTION
TICKER
SHARES
STATUS
joangraber • Aalto Investment Management Game (Fall 2020) • Nov 2020
buy and hold strategy, novartis is a big winner in the time of the covid crisis, they will aslo profit from the fact that the reimbursement caps in the United States will not be capped under a new administration, also a strategy of diversification
ACTION
TICKER
SHARES
STATUS
SteadyFund • Aalto Investment Management Game (Fall 2020) • Nov 2020
Initial investment according to fund's passive investment strategy (healthcare industry) with equal weighting. 4/6 largest companies measured by market cap in the fund's segment 4 (Pharmaceuticals and related segments).
ACTION
TICKER
SHARES
STATUS
Erottaja • Aalto Investment Management Game (Fall 2020) • Nov 2020
Passive Healthcare index investing strategy. 30 largest companies by market cap (Excluding the ones not available in Stockfuse). Following Spliced Health Care Index. Weight of NVS is 5.5%.
ACTION
TICKER
SHARES
STATUS
ACTION
TICKER
SHARES
STATUS